VIVA Targets 5% of India’s Louver Market with Its Next-Gen 0.7mm Aluminium System, Debuting at ACETECH Mumbai
MUMBAI, India, Nov. 4, 2025 /PRNewswire/ -- India's architectural design landscape is set…
Supermicro Announces U.S Federal Entity to Expand Further into the Federal Market — Extensive US-Based Manufacturing of AI Server Portfolio Targets the Federal Ecosystem
Delivers AI-optimized infrastructure, and energy-efficient computing systems, from the largest design and…
GENESIS MAGMA RACING TRAJECTORY PROGRAM EXCEEDS TARGETS DURING FIRST YEAR ON TRACK
The Genesis Magma Racing Trajectory Program has exceeded targets in its first…
Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a…
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3K Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglyc
Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT…
Questex’s IHIF Asia Delivers Record Deal-Making Activity as $280B in Capital Targets APAC Hotel Market
Major Acquisition Deal Originated at 2024 Event Highlights Conference's Role as Premier…
Flexsys Earns EcoVadis Platinum Rating and Validates Ambitious Science-Based Targets, Reinforcing Its Commitment to a Net-Zero, Sustainable Tire Industry
Milestones affirm Flexsys' leadership in sustainability, from top 1% recognition to credible near-term…
Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET…
Quanta Therapeutics Announces First Clinical Data Presentation for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE)…
ASM hosts Investor Day, provides new 2030 targets, revises H2 2025 outlook
Almere, The Netherlands September 23, 2025, 7:45 a.m. CET ASM International N.V.…
